Article · AI translation
IT Home reported on November 6 that Siemens Healthineers and Alibaba's DAMO Academy signed a strategic cooperation agreement on November 6 at the 9th China International Import Expo in Shanghai. They plan to combine DAMO Academy's pioneering “one scan, multiple screenings” AI technology with Siemens Healthineers' imaging equipment and clinical applications to help detect major diseases such as cancer and cardiovascular disease early.
According to the introduction, DAMO Academy developed its own “one scan, multiple screenings” technology based on non-contrast CT scans and AI. It uses AI to identify various subtle lesions in CT images that are difficult to distinguish with the naked eye. The technology has successively made breakthroughs on major international medical challenges, including imaging-based screening for digestive system tumors and early warning of aortic dissection. Related findings have appeared in leading journals including Science and Nature Medicine, entered the innovative medical device priority review channel of China's National Medical Products Administration, and received the US FDA's “Breakthrough Device” designation.
IT Home has learned that the two parties intend to draw on Siemens Healthineers' medical imaging equipment and clinical application resources and introduce DAMO Academy's medical AI models to promote the early detection, through a single CT scan, of highly lethal cancers including pancreatic, stomach, colorectal, esophageal and liver cancer, as well as critical cardiovascular conditions such as aortic dissection and pulmonary embolism.
In addition, using photon-counting CT, which is regarded within the industry as the most significant technological breakthrough of the past 10 years, the two parties will also work with leading institutions such as Ruijin Hospital on a series of AI studies, clinical validations and application rollouts, exploring how to detect even subtler early lesions with lower radiation doses.
DAMO Academy's AI has reportedly already provided more than 50 million instances of service to medical institutions in 10 countries and regions worldwide.